Publication | Open Access
The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration
86
Citations
74
References
2018
Year
ImmunologySynaptic SignalingSocial SciencesNeuroinflammationInflammationMolecular PharmacologyEndocytic PathwayAdvanced Glycation EndproductsNeurologyNeuroimmunologyCell SignalingMolecular SignalingMolecular PhysiologyMolecular NeuroscienceG Protein-coupled ReceptorMedicineReceptor (Biochemistry)Brain-immune InteractionVascular BiologyImmune FunctionInflammatory NeurodegenerationPharmacologyCell BiologySignal TransductionFunctional SelectivityNeuropeptide ReceptorNeuroscienceCentral Nervous SystemHigh Mobility GroupNeuropeptides
The Receptor for Advanced Glycation Endproducts (RAGE) is an immunoglobulin-type, transmembrane receptor that is expressed on numerous cell types in the Central Nervous System (CNS) and periphery, such as neurons, astrocytes, microglia, mononuclear phagocytes, epithelial cells and endothelial cells (ECs). RAGE binds a discrete repertoire of ligands, including non-enzymatically glycated proteins and lipids, also known as advanced glycation endproducts (AGEs), for which the receptor is named, in addition to multiple members of the S100/calgranulin family, oligomeric forms of Aβ, high mobility group box 1 (HMGB1), phosphatidylserine (PS) and lysophosphatidic acid.
| Year | Citations | |
|---|---|---|
Page 1
Page 1